5Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Human papillomavirus DNA versus Papanicalaou screening tests for cervical canccr[J]. N Engl J Med,2007,357(16) ; 1579-1588.
6Zhao FH, Lin MJ, Chen F, at al. Performance of high-risk human papitlomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population based studies from China[J]. Lancet Oncal, 2011,12(1) : 11.
7Wright TC Jr. Cervicalcancer screening in the 21st century： Is it time to retire the PAP smear[J]. Clin Obstet Gynecol, 2007,50 (2) ： 313-323.
8Kitchener HC, Gilham C, Sargent A, et al. A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervicalsceening:extended follow up in the ARTISTIC trial[J]. Eur J Cancer,2011,47(6) :864-871.
10Castle PE, Fetterman B, Poitras N, et al. Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting[J]. Obstet Gynecol, 2009,113 (3), 595-600.
4Syrjanen S,Shabalova IP,Petrovichev N,et al.Human papillomavirus testing and conventional Pap smear cytology as optional screening tools of women at different risks for cervical cancer in Countries of the former Soviet Union.J Low Genit Tract Dis,2002,6:97-110.
5Bosch FX,Manos MM,Munoz N,et al.Prevalence of human papillomavirus in cervical cancer:a worldwide perspective.International biological study on cervical cancer (IBSCC) Study Group.J Natl Cancer Inst,1995,87:796-802.
6Vizcaino AP,Moreno V,Bosch FX,et al.International trends in incidence of cervical cancer:Ⅱ.Squamous-cell carcinoma.Int J Cancer,2000,86:429-435.
7Munoz N,Bosch FX,de Sanjose S,et al.Epidemiologic classification of human papillomavirus types associated with cervical cancer.N Engl J Med,2003,348:518-527.
8Clavel C,Masure M,Bory JP,et al.Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions:a study of 7932 women.Br J Cancer,2001,84:1616-1623.
9Blumenthal PD,Gaffikin L,Chirenje ZM,et al.Adjunctive testing for cervical cancer in low resource settings with visual inspection,HPV,and the Pap smear.Int J Gynaecol Obstet,2001,72:47-53.
10Kuhn L,Denny L,Pollack A,et al.Human papillomavirus DNA testing for cervical cancer screening in low-resource settings.J Natl Cancer Inst,2000,92:818-825.
2Mayrand MH, Duarte-Franco E,Rodrigues I, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer[l]. N Engl J Med,2007,357 (16) : 1579-1588.
3Gold MA, Thomas MA, Huh WK, et al. High-risk humanpapillomavirus detection in women with low-grade squamouslesions or higher-grade cy- tology using the cervista HPV HR test[j]. J Low Genit Tract Dis, 2013,17 (1):51-57.
4Solomides CC, Bibbo M, Wang ZX. Assessment of fine needleaspiration specimen adequacy for high-risk HPV detectionand genotyping in oropha- ryngeal squarnous cell carcinoma[J], Acta Cytologica,2012,56 (2):196- 198.
